Hypnosis Competitors

The National Guild of Hypnotists, Inc. is a not-for-profit, educational corporation in the State of New Hampshire. Founded in Boston, Massachusetts in 1950 the Guild is a professional organization comprised of dedicated individuals committed to advancing the field of hypnotism. We provide an open forum for the free exchange of ideas concerning hypnotism. The Guild is a resource for members and a vehicle for legal and legislative action. We were established in 1950 by an enthusiastic group of hypnotists and Dr. Rexford L. North, Director of the Hypnotism Center of Boston, MA. Within a short time, local chapters were formed and operating in many major cities throughout the US and Canada. Important resources through the years have been The Journal of Hypnotism and The Hypno-Gram, the very first publications devoted exclusively to the field of hypnotism. This unique organization continues to encourage an eclectic exchange of ideas, fellowship, mutual trust and cooperation among members - while promoting and protecting the art, science and philosophy of hypnotism. As President and Executive Director, Dr. Dwight F. Damon has made it his mission to do everything possible to have our field recognized as a separate and distinct profession. The Guild has always assisted wherever needed, helping other groups and individuals in various states regardless of their affiliations. Each year the NGH holds an educational conference which is attended by hypnotists from all over the world. National Guild of Hypnotists P.O. Box 308 Merrimack, NH 03054-0308 Phone: 603.429.9438 Fax: 603.424.8066 Email: ngh@ngh.net

Founded in 1968 by Drs. John and Alex Kappas and celebrating over 50 years of excellence, HMI is a Non-Profit Organization that holds the distinction of being America’s First Nationally Accredited College of Hypnotherapy. Now HMI offers the convenience, flexibility, and safety of 100% Interactive Distance Learning.

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a non-profit organisation that brings together regulatory authorities and the pharmaceutical industry to discuss the scientific and technical aspects of pharmaceutical development. Through its working groups of regulatory and industry experts, ICH develops harmonised technical requirements to ensure the development and registration of safe, effective and high-quality medicines for humans. ICH also produces: • a standardised reference tool for medical terminology (MedDRA) that is now available in 27 languages; • a common format for submitting information to regulatory authorities (the Common Technical Document); • electronic standards for the transfer of regulatory information (ESTRI). Since it was created in 1990, ICH has finalized nearly 80 guidelines for technical requirements, which are increasingly applied by regulatory authorities around the world. As of October 2025, ICH has 23 members, 41 observers, and a network of nearly 700 experts globally. The ICH Association was registered as a non-profit legal entity under Swiss law in 2015.